olivLaw · US equity research
LQR House Inc. YHC
Beverages · SIC 2080 · Vertical: Beverages (SIC 2080)
At the close of 04 Nov 2026, LQR House Inc. (YHC) stock was 2.26 USD (−3.83% on the day), with market capitalisation 2.9 m USD, P/E 0.2 on diluted EPS of 10.73 USD over the last 12 months, beta 0.16, 52-week range 1.23–111.00 USD. Latest reported quarter (Q2 2026): revenue of 346.0 k USD (−30.6% YoY), net income of 2.7 m USD, diluted EPS 12.54 USD.
Data as of · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 52.6
- neutral
- Bollinger (20, 2)
- 1.23 – 2.97
- in the upper half of the band · %B 0.59 · band width 82.7%
- SMA 50 / 200
- 1.68 / 50.43
- mixed trend
- MACD (12, 26, 9)
- 0.15 / 0.10
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +79.4% | −1.1% | +80.5 pp | — |
| 3 months | +30.6% | −0.5% | +31.1 pp | — |
| 6 months | −97.5% | +4.4% | −101.9 pp | — |
| Year to date | −97.5% | +12.3% | −109.8 pp | — |
| 1 year | −97.3% | +13.5% | −110.9 pp | +6.7% |
| 3 years | −100.0% | +76.4% | −176.4 pp | −22.9% |
| 5 years | unavailable | +63.7% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 624.5 k | 838.2 k | 429.3 k | 498.5 k | 337.3 k | 299.7 k | 222.7 k | 346.0 k |
| Cost of revenue | 686.5 k | 857.6 k | 399.2 k | 414.0 k | 336.1 k | 246.3 k | 244.9 k | 300.1 k |
| Gross profit | -62.1 k | -19.4 k | 30.2 k | 84.5 k | 1.2 k | 53.4 k | -22.2 k | 45.9 k |
| Operating income | -3.5 m | -10.2 m | -2.4 m | -2.2 m | -3.8 m | -3.0 m | -2.9 m | -1.2 m |
| Interest expense | — | — | — | — | — | — | — | 263.0 k |
| Income tax | — | — | — | — | — | — | — | 0 |
| Net income | -3.4 m | -14.8 m | -2.4 m | -2.2 m | -16.8 m | -4.1 m | -915.0 k | 2.7 m |
| Diluted EPS | -21.84 | -73.54 ≈ | -3.85 | -110.18 | -1.50 | -0.27 ≈ | -0.04 | 12.54 |
| Operating cash flow | -1.0 m ≈ | -3.1 m | -6.6 m | -1.6 m ≈ | -11.3 m ≈ | -14.3 m | -1.5 m | -1.6 m ≈ |
| Share repurchases | 0 ≈ | 0 | — | — | — | — | — | — |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 0 percentile of its own 1-quarter history (min 0.7, median 0.7, max 0.7; quarters with earnings only).
Fiscal years
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 601.1 k | 1.1 m | 2.5 m | 1.6 m |
| Revenue YoY | unavailable | +86.4% | +123.2% | −37.4% |
| Net income | -1.8 m | -15.7 m | -22.8 m | -25.5 m |
| Net income YoY | unavailable | unavailable | unavailable | unavailable |
| Diluted EPS | -8.17 | -17.01 | -144.33 | -3.51 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable |
| net % | -306.5% | -1,405.3% | -909.6% | -1,631.0% |
| Free cash flow | unavailable | -9.1 m | unavailable | -34.2 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 6.0 m USD
- Financial debt
- 7.2 m USD
- Net debt
- 1.2 m USD
- Equity
- 29.3 m USD
- Total assets
- 31.2 m USD
- Debt / equity
- 0.25x
- Current ratio
- 8.60x
- ROE
- unavailable
- ROA
- -133.7%
- FCF margin
- -2,182.8%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Revenue | 601.1 k | 1.1 m | 2.5 m | 1.6 m | SEC (XBRL)· 15 Apr 2026verified |
| Cost of revenue | 803.1 k | 915.6 k | 2.8 m | 1.4 m | SEC (XBRL)· 15 Apr 2026verified |
| Gross profit | -202.0 k | 205.0 k | -313.2 k | 169.3 k | SEC (XBRL)· 15 Apr 2026verified |
| Operating income | -1.8 m | -15.6 m | -18.5 m | -11.4 m | SEC (XBRL)· 15 Apr 2026verified |
| Interest expense | — | 171.0 k | — | — | SEC (XBRL)· 01 Apr 2024verified |
| Net income | -1.8 m | -15.7 m | -22.8 m | -25.5 m | SEC (XBRL)· 15 Apr 2026verified |
| Diluted EPS | -8.17 | -17.01 | -144.33 | -3.51 | SEC (XBRL)· 15 Apr 2026verified |
| Weighted average diluted shares | 225.4 k | 925.6 k | 157.7 k | 7.3 m | SEC (XBRL)· 15 Apr 2026verified |
Balance sheet · USD
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Cash | 7.6 k | 7.1 m | 5.4 m | 6.0 m | SEC (XBRL)· 19 Aug 2026verified |
| Receivables | — | — | 28.0 k | 23.9 k | SEC (XBRL)· 15 Apr 2026verified |
| Current assets | 547.0 k | 15.1 m | 5.8 m | 16.0 m | SEC (XBRL)· 15 Apr 2026verified |
| Property, plant & equipment, net | — | — | — | 312.2 k | SEC (XBRL)· 15 Apr 2026verified |
| Intangibles (excl. goodwill) | 2.1 m | 10.0 k | 10.0 k | — | SEC (XBRL)· 31 Mar 2025verified |
| Total assets | 2.6 m | 15.1 m | 6.9 m | 31.2 m | SEC (XBRL)· 15 Apr 2026verified |
| Accounts payable | 287.5 k | 265.2 k | 530.6 k | 76.5 k | SEC (XBRL)· 15 Apr 2026verified |
| Short-term debt | — | — | — | 7.2 m | SEC (XBRL)· 19 Aug 2026verified |
| Current liabilities | 590.7 k | 469.7 k | 7.5 m | 1.9 m | SEC (XBRL)· 15 Apr 2026verified |
| Total liabilities | 590.7 k | 472.3 k | 7.5 m | 1.9 m | SEC (XBRL)· 15 Apr 2026verified |
| Equity | 2.0 m † | 14.6 m † | -518.0 k † | 29.3 m | SEC (XBRL)· 19 Aug 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|
| Operating cash flow | -918.2 k | -9.1 m | -6.6 m | -33.8 m | SEC (XBRL)· 15 Apr 2026verified |
| Capex | — | 10.0 k | — | 340.5 k | SEC (XBRL)· 15 Apr 2026verified |
| Free cash flow | — | -9.1 m ≈ | — | -34.2 m ≈ | SEC (XBRL)· 15 Apr 2026derived |
| Investing cash flow | -190.3 k | -5.3 m | 675.7 k | -18.8 m | SEC (XBRL)· 15 Apr 2026verified |
| Financing cash flow | — | 21.5 m | 4.3 m | 53.2 m | SEC (XBRL)· 15 Apr 2026verified |
| Share repurchases | — | 1.5 m | 547.4 k | — | SEC (XBRL)· 31 Mar 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 47.9% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 2.9 m USD
Key indicators
Coverage and freshness
Score by group
48% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 239.32 – 365.45 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · the reported interest expense is far older than the latest period (the filer changed its XBRL tag): a stale figure is not used
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/E239.32 – 365.45 (Mid 327.61)6 companies used · median multiple 30.5x · quartiles 22.3x – 34.1xBF-A, BUDA, COCO, KDP, KO, PEP
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 47.9% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | -6.7% | 23 (vs peers) | 22% |
| Net margin · Quality | -1,589.2% | 12 (vs peers) | 13% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | 37.6% | 100 (on a fixed band) | 17% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 1.0x | 14 (on a fixed band) | 9% |
| P/E (TTM) · Valuation | 0.2x | 100 (vs peers) | 22% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -980.7% | 0 (on a fixed band) | 17% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial14/100 · 1/3 factors with a value
- Growth· partial100/100 · 1/2 factors with a value
- Quality19/100 · 2/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation56/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
LQR House Inc. (YHC). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 1.6 m USD in 2025; YoY growth -37.4%; net margin -1,589.2%; ROE -88.2%.
The estimated value range is 239.32–365.45 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 327.61 USD, the price of 2.26 USD leaves a potential of 14,396.2% (value / price − 1) and a margin of safety of 99.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 47.9% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Revenue CAGR 3Y: 37.6%
- P/E (TTM): 0.2x
- The price is below the estimated value range
What contradicts it
- ROIC: -6.7%
- Net margin: -1,589.2%
- Current ratio: 1.0x
- FCF yield: -980.7%
Not assessed (insufficient data or a ratio without meaning): FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Beverages (SIC 2080) · same industry (4-digit SIC) · compared with 17 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| KOCoca Cola Co | 412.1 bn | 28.2 | 42.6% | 28.7% | +1.9% | +31% / +64% |
| DEODIAGEO plc | 237.6 bn | 92.4 | 24.0% | 9.1% | +0.3% | +7% / −30% |
| PEPPepsico Inc | 194.1 bn | 18.7 | 50.1% | 10.8% | +2.3% | −4% / −15% |
| KDPKeurig Dr Pepper Inc. | 50.1 bn | 37.2 | 5.7% | 7.1% | +8.2% | +32% / +17% |
| BF-ABrown Forman Corp | 14.9 bn | 20.3 | 18.1% | 18.4% | −1.2% | +10% / −48% |
| PRMBPrimo Brands Corp | 7.6 bn | 79.4 | 3.2% | 1.5% | +29.3% | +34% / +46% |
| COCOThe Vita Coco Company, Inc. | 3.7 bn | 32.9 | 32.0% | 15.7% | +18.2% | +23% / +133% |
| WESTWestrock Coffee Company | 1.0 bn | — | — | -4.9% | +39.8% | +138% / +13% |
| BUDABuda Juice, Inc. | 83.2 m | 34.5 | 19.3% | 17.1% | +11.8% | unavailable / unavailable |
| SRXHSRX Global Inc. | 18.0 m | — | -70.8% | -254.8% | −81.3% | −96% / −100% |
| WVVIWillamette Valley Vineyards, Inc. | 8.3 m | — | -3.3% | -5.9% | −6.5% | −37% / −68% |
| YHCLQR House Inc. | 2.9 m | 0.2 | -88.2% | -1,589.2% | −37.4% | −97% / −100% |
| IPSTIp Strategy Holdings, Inc. | 2.3 m | — | -2,713.2% | -2,064.0% | +20.4% | −98% / unavailable |
| EDVAEndovia Health Sciences, Inc. | 1.2 m | — | — | -53,856.5% | −90.9% | −96% / −100% |
| BRCCBRC Inc. | 903.4 k | — | -14.2% | -1.5% | +1.7% | −23% / −77% |
| IBGInnovation Beverage Group Limited | 593.4 k | — | — | -223.4% | −5.1% | −94% / unavailable |
| STZConstellation Brands, Inc. | — | — | 23.9% | 20.9% | −10.5% | +7% / −40% |
| ABEVAmbev S.A. | — | — | 16.6% | 17.6% | −1.4% | +9% / +1% |
1- and 3-year price returns: for YHC from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report26 Oct 2026Regulation FD disclosure · Financial statements and exhibits
- Current report23 Oct 2026Departure or appointment of officers
- Current report19 Oct 2026Regulation FD disclosure · Financial statements and exhibits
- Current report16 Oct 2026Material agreement · Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits
- Quarterly report19 Aug 2026
- Current report (amendment)10 Aug 2026Acquisition or disposition of assets · Financial statements and exhibits
- Current report15 Jul 2026Amendments to articles or bylaws · Regulation FD disclosure · Financial statements and exhibits
- Current report02 Jul 2026Other events
- Current report30 Jun 2026Regulation FD disclosure · Financial statements and exhibits
- Current report04 Jun 2026Departure or appointment of officers
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.